Rodney L. Nussbaum - 20 Mar 2024 Form 4 Insider Report for GYRE THERAPEUTICS, INC. (GYRE)

Role
Director
Signature
/s/ Ruoyu Chen, as attorney-in-fact for Rodney Nussbaum
Issuer symbol
GYRE
Transactions as of
20 Mar 2024
Net transactions value
$0
Form type
4
Filing time
21 Mar 2024, 20:31:12 UTC
Next filing
16 Aug 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GYRE Stock Option (Right to Buy) Award $0 +1,866 $0.000000 1,866 20 Mar 2024 Common Stock 1,866 $17.86 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These options vest as to one-third on each of the first, second and third anniversaries of the grant date, subject to the Reporting Person's continued service to the Issuer through each vesting date.